Trastuzumab - 20mg/ml in PBS

CAS: 180288-69-1

Ref. 3D-FT65040

Información del producto

• Nombre: Trastuzumab - 20mg/ml in PBS
• Sinónimos: Trastuzumab Herceptin Immunoglobulin G1 Hervycta
• Marca: Biosynth
• Descripción: Trastuzumab is a humanised immunoglobulin G1 monoclonal antibody against human epidermal growth factor receptor 2 (HER2), used in breast cancer treatments. Some potential extracellular and intracellular antitumor mechanisms of trastuzumab have been proposed, including activation of antibody-dependent cellular cytotoxicity, inhibition of extracellular domain cleavage, abrogation of intracellular signalling, reduction of angiogenesis and decreased DNA repair that result in tumour cell stasis and/or death. Its drug conjugate, trastuzumab deruxtecan (T-DXd), is used in the clinical therapy for pretreated HER2-mutant non-small cell lung cancer (NSCLC).

Propiedades químicas

• Pureza: Min. 95 Area-%
• Color/Forma: Clear Liquid